{"id":51518,"date":"2022-12-02T18:02:24","date_gmt":"2022-12-02T17:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/"},"modified":"2022-12-02T18:02:24","modified_gmt":"2022-12-02T17:02:24","slug":"everest-clinical-research-announces-the-acquisition-of-brightech-international","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/","title":{"rendered":"Everest Clinical Research Announces the Acquisition of Brightech International"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–Everest Clinical Research (\u201cEverest\u201d), a leading full-service contract research organization (\u201cCRO\u201d) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (\u201cBrightech\u201d).\n<\/p>\n

\nFounded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a highly-regarded reputation as a critical partner for some of the world\u2019s largest pharmaceutical and biotech companies. In addition to its New Jersey headquarters, Brightech has an expanded global reach with a second office in Asia. Brightech will continue to be led by Dr. Tai Xie, the company\u2019s CEO and founder, and the existing management team.\n<\/p>\n

\nCommenting on the announcement, Everest CEO Irene Zhang said, \u201cWe are extremely excited to partner with Dr. Xie and his entire team as we continue to expand Everest\u2019s world-class capabilities. Brightech brings with it a highly educated, experienced, and dedicated workforce, including numerous PhDs and Master\u2019s degree holders. With our combined deep bench of biostatistical and clinical data management capabilities, Everest\u2019s broader full-service clinical trial services, and now over 520 employees globally, we will be even better positioned to solve our clients\u2019 most challenging problems.\u201d\n<\/p>\n

\nDr. Xie, CEO of Brightech, added, \u201cThere is an incredibly strong fit between our two organizations. We both have deeply engrained cultures of innovation, dedication to our customers, and offering high quality services. We look forward to working together with Everest teams.\u201d He added, \u201cEverest\u2019s scale, resources, and infrastructure will allow us to broaden the scope of our services to existing and future customers while also providing our employees with even more opportunities.\u201d\n<\/p>\n

\nJin Dai, Executive Director of Project Management and Business Operations said, \u201cThis highly complementary partnership will further bolster Everest\u2019s capabilities in our fast-growing foundational biometrics offerings, especially in major therapeutic areas like Oncology, Central Nervous System, and Immunology, and will help further our mission of helping develop critical and often lifesaving treatments for patients worldwide.\u201d\n<\/p>\n

\nAbout Everest<\/b>\n<\/p>\n

\nEverest is a full-service contract research organization (\u201cCRO\u201d) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. Everest serves some of the best-known companies and works with many of the most advanced drugs, biologics, and medical devices in development today. Founded in 2004, Everest has a strong foundation as a statistical and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Operating primarily in North America, with headquarters located in Toronto, Ontario, Canada, a second office in Little Falls, New Jersey, USA and a third office in Shanghai, China, Everest is known in the industry for its high quality deliverables, superior customer service, and flexibility in meeting clients\u2019 needs.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nIrene Zhang and Jin Dai
\n
Everest Clinical Research Corporation
\n
675 Cochrane Drive, East Tower, 4th Floor
\n
Markham, ON L3R 0B8, Canada
\n
905-752-5222\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO–(BUSINESS WIRE)–Everest Clinical Research (\u201cEverest\u201d), a leading full-service contract research organization (\u201cCRO\u201d) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (\u201cBrightech\u201d). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51518","6":"format-standard","7":"category-industry"},"yoast_head":"\nEverest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Everest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO–(BUSINESS WIRE)–Everest Clinical Research (\u201cEverest\u201d), a leading full-service contract research organization (\u201cCRO\u201d) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (\u201cBrightech\u201d). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-02T17:02:24+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Everest Clinical Research Announces the Acquisition of Brightech International\",\"datePublished\":\"2022-12-02T17:02:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/\"},\"wordCount\":492,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/\",\"name\":\"Everest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-12-02T17:02:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/everest-clinical-research-announces-the-acquisition-of-brightech-international\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Everest Clinical Research Announces the Acquisition of Brightech International\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Everest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/","og_locale":"en_US","og_type":"article","og_title":"Everest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend","og_description":"TORONTO–(BUSINESS WIRE)–Everest Clinical Research (\u201cEverest\u201d), a leading full-service contract research organization (\u201cCRO\u201d) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (\u201cBrightech\u201d). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-02T17:02:24+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Everest Clinical Research Announces the Acquisition of Brightech International","datePublished":"2022-12-02T17:02:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/"},"wordCount":492,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/","url":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/","name":"Everest Clinical Research Announces the Acquisition of Brightech International - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-12-02T17:02:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/everest-clinical-research-announces-the-acquisition-of-brightech-international\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Everest Clinical Research Announces the Acquisition of Brightech International"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51518"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51518\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}